Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Feb;9(1):398-407.
doi: 10.1002/ehf2.13737. Epub 2021 Dec 4.

Acute heart failure and iron deficiency: a prospective, multicentre, observational study

Affiliations
Observational Study

Acute heart failure and iron deficiency: a prospective, multicentre, observational study

Dirk H van Dalen et al. ESC Heart Fail. 2022 Feb.

Abstract

Aims: The prevalence and the natural course of iron deficiency (ID) in acute heart failure (AHF) are still unclear. We investigated the prevalence of ID in unselected patients admitted with AHF on admission, at discharge and up to 3 months thereafter.

Methods and results: In this prospective, multicentre, observational study, 742 patients admitted with AHF were enrolled. The main study outcome was the percentage of patients with ID (ferritin <100 μg/L = absolute ID or ferritin 100-299 μg/L and transferrin saturation <20% = functional ID) at admission (T0), after clinical stabilization prior to discharge (T1), and 10 ± 6 weeks after discharge (T2). At T0, ID was present in 71.8% of the patients (44.1% absolute and 27.7% functional ID). At T1 and T2, ID was present in 56.4% (32.4% absolute and 24% functional ID) and 50.3% (36.8% absolute and 13.5% functional ID), respectively. Absolute ID persisted from T0 to T2 in 66% of the patients, while functional ID resolved in 56% of the patients. Ferritin (median [interquartile range] 124 μg/L [56-247] to 150 μg/L [73-277]), transferrin saturation (15% [10-20] to 18% [12-27]), and iron levels (9 μmol/L [6-13] to 11 μmol/L [8-16]) increased significantly (all P < 0.001) from T0 to T1. Transferrin saturation (to 21% [15-29]) and iron levels (to 13 μmol/L [9-17]) also increased significantly (both P < 0.01) from T1 to T2 without iron supplementation.

Conclusions: Iron deficiency is highly prevalent in patients with AHF, but resolves during treatment in some patients, even without iron supplementation. Absolute ID is more likely to persist over time, whereas functional ID often resolves during treatment of AHF, representing probably a reduced iron availability rather than a true deficiency.

Keywords: Acute decompensated heart failure; Comorbidity; Functional iron deficiency; Iron availability disorder; Iron deficiency; Worsening heart failure.

PubMed Disclaimer

Conflict of interest statement

H‐PB‐LR, CvD, and ME report receiving advisory board fees and lecture fees from Vifor Pharma. HK and CK received lecture fees from Vifor Pharma. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Number of patients included at different time points.
Figure 2
Figure 2
Iron deficiency (ID) at hospital admission (T0).
Figure 3
Figure 3
Iron deficiency (ID) at the different time points and variability between groups. Width of lines between groups indicates number of patients (1 pt = 10 patients).
Figure 4
Figure 4
Levels of ferritin (left), transferrin saturation (middle) and serum iron (right) at the three time points in those patients having iron status measured at all time points. The boundaries of the box are Tukey's hinges; extremes are not shown.

References

    1. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin‐Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010; 31: 1872–1880. - PubMed
    1. von Haehling S, Gremmler U, Krumm M, Mibach F, Schön N, Taggeselle J, Dahm JB, Angermann CE. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP Registry. Clin Res Cardiol 2017; 106: 436–443. - PMC - PubMed
    1. Klip IT, Comin‐Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 2013; 165: 575–582.e3. - PubMed
    1. Beale A, Carballo D, Stirnemann J, Garin N, Agoritsas T, Serratrice J, Kaye D, Meyer P, Carballo S. Iron deficiency in acute decompensated heart failure. J Clin Med 2019; 8: 1569. - PMC - PubMed
    1. Cohen‐Solal A, Damy T, Terbah M, Kerebel S, Baguet JP, Hanon O, Zannad F, Laperche T, Leclercq C, Concas V, Duvillié L, Darné B, Anker S, Mebazaa A. High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur J Heart Fail 2014; 16: 984–991. - PubMed

Publication types

LinkOut - more resources